JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 53 filers reported holding JUNIPER PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $2,397,000 | +54.7% | 275,506 | +80.5% | 0.01% | +42.9% |
Q1 2018 | $1,549,000 | +373.7% | 152,613 | +126.9% | 0.01% | +600.0% |
Q4 2017 | $327,000 | +71.2% | 67,269 | +59.9% | 0.00% | 0.0% |
Q3 2017 | $191,000 | -9.5% | 42,068 | +0.2% | 0.00% | 0.0% |
Q2 2017 | $211,000 | +7.7% | 41,978 | +2.3% | 0.00% | 0.0% |
Q1 2017 | $196,000 | -9.7% | 41,037 | +6.6% | 0.00% | 0.0% |
Q4 2016 | $217,000 | -10.3% | 38,493 | -11.4% | 0.00% | 0.0% |
Q3 2016 | $242,000 | -50.5% | 43,430 | -37.8% | 0.00% | -50.0% |
Q2 2016 | $489,000 | -43.5% | 69,810 | -46.7% | 0.00% | -50.0% |
Q1 2016 | $866,000 | -46.0% | 130,858 | -16.0% | 0.00% | -50.0% |
Q4 2015 | $1,604,000 | +50.5% | 155,747 | +72.0% | 0.01% | +33.3% |
Q3 2015 | $1,066,000 | +5230.0% | 90,529 | +3945.1% | 0.01% | – |
Q2 2015 | $20,000 | – | 2,238 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 481,459 | $5,672,000 | 2.05% |
Krensavage Asset Management, LLC | 279,717 | $3,295,000 | 1.19% |
EAM Investors, LLC | 145,898 | $1,719,000 | 0.27% |
PERRITT CAPITAL MANAGEMENT INC | 93,000 | $1,096,000 | 0.23% |
TFS CAPITAL LLC | 99,823 | $1,176,000 | 0.11% |
Bellevue Asset Management AG | 50,000 | $589,000 | 0.10% |
CADENCE CAPITAL MANAGEMENT LLC | 88,232 | $1,039,000 | 0.07% |
Spark Investment Management LLC | 39,200 | $461,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 100,564 | $1,185,000 | 0.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 35,599 | $419,000 | 0.03% |